Vital Signs - Contract Research and Manufacturing Services: Best Practices, Investment Strategy and Deal-Making
Vital Signs - Contract Research and Manufacturing Services: Best Practices, Investment Strategy and Deal-Making
RELEASE DATE
05-Apr-2010
05-Apr-2010
REGION
North America
North America
Research Code: 9561-00-A3-00-00
SKU: HC00592-NA-MR_04065
$1,500.00
Special Price $1,125.00 save 25 %
In stock
SKU
HC00592-NA-MR_04065
Description
This issue of Vital Signs, released on April 6, 2010, provides a strategic overview of current trends and issues impacting contract research and manufacturing in the pharma & biotech industry. Additionally, a company spotlight is provided for Vaccinogen, a biotechnology company with more than three decades of research into combating cancer by using the body’s own immune system. Reimbursement and regulatory news from the FDA is also provided for the week of March 15, 2010.
Table of Contents
This week's issue:
Popular Topics
This issue of Vital Signs, released on April 6, 2010, provides a strategic overview of current trends and issues impacting contract research and manufacturing in the pharma & biotech industry. Additionally, a company spotlight is provided for Vaccinogen, a biotechnology company with more than three decades of research into combating cancer by using the bodys own immune system. Reimbursement and regulatory news from the FDA is also provided for the week of March 15, 2010.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-A3-00-00 |
Is Prebook | No |